Optimizing Pediatric Antiarrhythmic Therapy: A Review of Efficacy and Safety

Sujal Y. Tale , Jaydeep D. Wankhade , Akshay P. Tale , Aditya P. Fande , Shreyash S. Padmawar

children; antiarrhythmic drugs; arrhythmia; electrophysiology; drug dosing

In light of differences in medication availability, regulatory approvals, and clinical expertise, tailored treatment plans are critical when managing pediatric arrhythmias. Certain drugs, like amiodarone, esmolol, and adenosine, have specific dosage recommendations, but other drugs, like digoxin or sotalol, don't. It is essential to compile and abide by published dosage recommendations for antiarrhythmic medications in children in order to reduce the risk of dosing errors and uncertainties. Healthcare institutions can ensure the safe and effective management of pediatric arrhythmias while taking into account the specific factors influencing drug administration and patient outcomes by creating center-specific protocols for antiarrhythmic drug therapy. There are few official guidelines and consensus documents regarding the treatment of pediatric arrhythmias; some drugs have standardized dosing recommendations, while others only possess broad directives. It is crucial to summarize published dosage recommendations for antiarrhythmic medications in children in order to address dosing uncertainties. Considering the vast differences in accessibility, legal authorization, and clinical background, each center should create its own unique protocols for pediatric antiarrhythmic medication therapy. For pediatric patients with arrhythmias, this method guarantees individualized and optimal treatment plans that account for differences in medication availability, regulatory clearance, and clinical knowledge.

Published Paper   E-Certificate

"Optimizing Pediatric Antiarrhythmic Therapy: A Review of Efficacy and Safety", IJSDR - International Journal of Scientific Development and Research (www.IJSDR.org), ISSN:2455-2631, Vol.9, Issue 3, page no.603 - 613, March-2024, Available :https://ijsdr.org/papers/IJSDR2403089.pdf

Volume 9 Issue 3, March-2024

Pages : 603 - 613

Paper Reg. ID: IJSDR_210514

Published Paper Id: IJSDR2403089

Downloads: 000347084

Research Area: Pharmacy

Country: Amravati, Mahashtra, India

Published Paper PDF: https://ijsdr.org/papers/IJSDR2403089

Published Paper URL: https://ijsdr.org/viewpaperforall?paper=IJSDR2403089

ISSN: 2455-2631 | IMPACT FACTOR: 9.15 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 9.15 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJSDR(IJ Publication) Janvi Wave

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition